Dermtech signs a commercial & medicare advantage coverage agreement
Category: #health  | By Mateen Dalal  | Date: 2020-01-18 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Dermtech signs a commercial & medicare advantage coverage agreement

DermTech Inc., a San Diego based biotechnology company that is involved in precision dermatology, has recently announced signing a contract with a regional health plan to develop its gene expression based PLA (Pigmented Lesion Assay) for prior detection of melanoma available to the regional health plan’s Medicare Advantage and commercial members.

This agreement marks the health plan’s first contract that would offer coverage for PLA. Apparently, DermTech’s pigmented lesion assay comes as the first-ever, non-invasive gene expression test that detects melanoma at an early stage. PLA holds a 99% negative predictive value, which means that the possibility of the PLA missing a melanoma is under 1% when administered correctly.

Speaking on the development, Dan Visage, Senior Vice President of Payor Access, Dermtech, said that the company is thrilled to reveal that its test is currently accessible by a segment of medicare advantage and commercial members.

Payor Access’ PLA test delivers substantial benefits in early melanoma identification and condensed biopsies of benign lesions. These tests would lower the cost to the healthcare system, cites Visage.

Prior to this news, Dermtech had made headlines when it expanded its intellectual property by issuing the patent US10,407,729. This patent published by the US Patent Office was labeled “Diagnosis of melanoma by nucleic acid analysis” and involved claims in association with the firm’s technology to non-invasively attain genomic evidence for illustrating skin lesions 

As per Dr. Zuxu Yao, Chief Scientific Officer, DermTech, this patent highlights their firm’s ability to non-invasively achieve significant genomic data and expands its previous work. DermTech’s technology offers actionable genomic information that can’t be visually determined.

Providing data on crucial targets like PRAME without the help of surgical biopsies, holds the potential to augment the dermatology practice, claims Dr. Yao.

Source Credit: https://investors.dermtech.com/news-releases/news-release-details/dermtech-enters-commercial-and-medicare-advantage-payor-coverage

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

Oral-B & iADH partner to make oral care positive & accessible for all

Oral-B & iADH partner to make oral care positive & accessible for all

By Mateen Dalal

Oral-B, a well-known American oral hygiene products brand, has reportedly inked a partnership deal with iADH (International Association of Disability and Oral Health), in order to make oral care more positive, accessible, and inclusive for disabled p...

NEA AND SLA SIGN MOU TO SHARE GLOBAL NAVIGATION SATELLITE SYSTEM (GNSS)-DERIVED MOISTURE DATA FOR WEATHER MONITORING APPLICATION

NEA AND SLA SIGN MOU TO SHARE GLOBAL NAVIGATION SATELLITE SYSTEM (GNSS)-DERIVED MOISTURE DATA FOR WEATHER MONITORING APPLICATION

By Mateen Dalal

Singapore, 2 August 2022 – The National Environment Agency (NEA) and the Singapore Land Authority (SLA) have signed a Memorandum of Understanding (MOU) to develop the use of Global Navigation Satellite System (GNSS) data obtained from SLA&rsqu...

Baidu launches Apollo RT6; seeks expansion of its robotaxi fleet

Baidu launches Apollo RT6; seeks expansion of its robotaxi fleet

By Mateen Dalal

Baidu, a leading China-based artificial intelligence (AI) company and search engine, has reportedly uncovered its most recent electric autonomous driving vehicle. As per credible sources, the new vehicle, Apollo RT6, will be a part of the robotaxi...